Hinge Health Revenue Hits $235.0 Million, Beating Third-Quarter Expectations
Key Facts
Hinge Health reported third-quarter results on November 2, 2026, after U.S. markets closed, for the period ended September 30, posting revenue of $235.0 million and adjusted earnings of $0.71 per share. A summary of coverage carried by Benzinga via MarketScreener said both figures beat analysts’ expectations. Revenue came in above the company’s previous range of $223 million to $225 million. Management had forecast annual growth of 45% at the midpoint of that range. The focus of results coverage has therefore shifted from the reporting date to what the actual figures mean against the company’s previous guidance.
Actual revenue exceeded the top end of the quarterly guidance range, which the company reported in its second-quarter results supplement. The guidance put non-GAAP operating income at $61 million to $63 million, alongside expected revenue. The available summary of third-quarter coverage reports revenue and adjusted earnings per share, but does not include a figure for actual operating income or an update to full-year guidance. A detailed comparison of operating performance with management’s previous targets therefore remains tied to figures the company will present in its results materials. The company scheduled its results call for the day of the announcement at 1:30 p.m. Pacific time, or 4:30 p.m. Eastern time.
The revenue result follows a second quarter in which the company recorded annual growth of 53%, with revenue of $212.8 million compared with $139.1 million in the second quarter of 2025. On operating profitability, non-GAAP operating income rose to $61.5 million, compared with $26.1 million in the year-earlier period, an annual increase of 136%. The operating margin on the same basis was 29%, versus 19% a year earlier. GAAP diluted net income came to $0.52 per share, after a diluted loss of $13.10 per share in the second quarter of 2025. These metrics illustrate the different profitability measures used by the company, as non-GAAP operating income is not the same as net income under accounting standards.
Free cash flow was $99.6 million in the second quarter of 2026, compared with $32.6 million in the year-earlier period. As its business expanded, Hinge Health had about 2,929 clients as of June 30, 2026, up 24% from 2,359 clients on the same date a year earlier. Co-CEO Daniel Perez attributed the second-quarter outperformance to continued improvement in member conversions, along with improvements to the member experience and outcomes and lower client costs. These figures provide an operating backdrop for assessing revenue growth through client, conversion and cash flow metrics. The company said in its third-quarter 2025 results that it had surpassed 1.5 million members over its operating history, alongside revenue growth and record free cash flow.
Hinge Health raised its fiscal 2026 revenue guidance in August to a range of $856 million to $860 million, reflecting annual growth of 46% at the midpoint, and raised its non-GAAP operating income forecast to $236 million to $244 million. The available results summary does not include an update to this full-year outlook, making it an important focus of the company’s call after the quarterly figures were reported. On service expansion, the company announced an agreement in August to acquire Cylinder Health for $105 million in cash. It said the deal aims to add an integrated digestive health care program to its existing services, with the program expected to launch in 2027. The results place the quarter in the context of the company’s plans to expand alongside its existing musculoskeletal and migraine care business.